文献速递物质与行为成瘾心境障碍焦虑、强迫与应激相关障碍

阿片类药物相关死亡前的医疗服务使用模式

Service Use Preceding Opioid-Related Fatality.
PubMed 文献 · Am J Psychiatry · 2017-11-28

本研究分析医疗补助计划中≤64岁阿片类药物相关死亡者死亡前30天和12个月的临床诊断、处方及非致死性中毒事件。61.5%死者生前一年有慢性非癌性疼痛诊断,该组更常填充阿片类和苯二氮䓬类药物处方,且药物使用、抑郁或焦虑障碍诊断更常见,但临终前阿片使用障碍诊断罕见。

要点

  • 多数阿片相关死亡者有慢性非癌性疼痛诊断(61.5%)。
  • 慢性疼痛组死亡前30天阿片类(49.0% vs 17.2%)和苯二氮䓬类(52.1% vs 26.6%)处方填充率更高。
  • 两组临终前阿片使用障碍诊断均少见(4.2% vs 4.3%)。

核心结论

  • 阿片相关死亡者,尤其慢性疼痛患者,临终前一年常接受药物使用障碍和精神障碍相关服务,但临近死亡时阿片使用障碍诊断罕见。

研究设计与样本

  • 研究纳入医疗补助计划中≤64岁的阿片相关死亡者13,089例,按最后一年有无慢性非癌性疼痛诊断分组。
  • 分析死亡前30天和12个月的临床诊断、处方填充及非致死性中毒事件。

主要发现

  • 61.5%的死者最后一年有慢性非癌性疼痛诊断。
  • 慢性疼痛组较无疼痛组更常填充阿片类(49.0% vs 17.2%)和苯二氮䓬类(52.1% vs 26.6%)处方(死亡前30天)。
  • 慢性疼痛组更常被诊断药物使用障碍(40.8% vs 22.1%)、抑郁(29.6% vs 13.0%)或焦虑(25.8% vs 8.4%)障碍(死亡前一年)。
  • 两组死亡前30天阿片使用障碍诊断均不常见(4.2% vs 4.3%)。

临床怎么用

  • 对慢性非癌性疼痛患者应加强阿片类和苯二氮䓬类处方管理,并筛查药物使用及精神障碍。
  • 临终前阿片使用障碍诊断率低,提示需提高对该人群阿片使用障碍的识别。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study analyzed health service patterns before opioid-related death among nonelderly individuals in the Medicaid program, focusing on decedents with and without past-year diagnoses of noncancer chronic pain. METHODS: The authors identified opioid-related decedents, age ≤64 years, in the Medicaid program and characterized their clinical diagnoses, filled medication prescriptions, and nonfatal poisoning events during the 30 days and 12 months before death. The study group included 13,089 opioid-related deaths partitioned by presence or absence of chronic noncancer pain diagnoses in the last year of life. RESULTS: Most decedents (61.5%) had received clinical diagnoses of chronic noncancer pain conditions in the last year of life. As compared with decedents without chronic pain diagnoses, those with these diagnoses were significantly more likely to have filled prescriptions for opioids (49.0% versus 17.2%) and benzodiazepines (52.1% versus 26.6%) during the last 30 days of life, while diagnoses of opioid use disorder during this period were uncommon in both groups (4.2% versus 4.3%). The chronic pain group was also significantly more likely than the nonpain group to receive clinical diagnoses of drug use (40.8% versus 22.1%), depression (29.6% versus 13.0%) or anxiety (25.8% versus 8.4%) disorders during the last year of life. CONCLUSIONS: Persons dying of opioid-related causes, particularly those who were diagnosed with chronic pain conditions, commonly received services related to drug use disorders and mental disorders in the last year of life, though opioid use disorder diagnoses near the time of death were rare.

来源:Am J Psychiatry,查看原文。版权归原作者所有。

引用

  1. Olfson M, Wall M, Wang S, et al. Service Use Preceding Opioid-Related Fatality. Am J Psychiatry. 2017. PMID: 29179577. doi:10.1176/appi.ajp.2017.17070808

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。